Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung

7680670940023 CH-67094 Konzentrat
Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
Libtayo 350 mg/7 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/09/2025
Summary of Product Characteristics
Français
05/09/2025
Summary of Product Characteristics
Italien
05/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
350.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 3811.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2022

Authorization holder

Regeneron Switzerland GmbH

4052 Basel

Authorization information

Swissmedic authorization number
67094
Drug name
Libtayo, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L01FF06
Authorization status
Z
Dispensing category
A
First authorization
27/05/2020
Authorization expiration date
04/10/2027
IT Number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Package details

Description (FR)
LIBTAYO conc perf 350 mg/7ml flac 7 ml
Description (DE)
LIBTAYO Inf Konz 350 mg/7ml Durchstf 7 ml
Market launch
27/05/2020
Narcotic (BTM)
No